Mode
Text Size
Log in / Sign up
N/A N=31 Randomized Quadruple-blind Prevention

Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

Respiratory Distress Syndrome in Premature Infants · Very Low Birth Weight Baby

Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcome: Primary: Maximum Factional Inspired Oxygen Percent (FiO2) — 48; 39 percentage of Inspired Oxygen — p=0.0012

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
iNO (Drug); Nitrogen (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
University of Oklahoma
Primary completion
Jan 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Maximum Factional Inspired Oxygen Percent (FiO2)
48; 39 0.0012 sig
PRIMARY
Rate of Hyperoxia
708; 370 <0.0001 sig
PRIMARY
Pre and Postductal Saturation Levels
90.5; 82.8; 79.9; 78.2
PRIMARY
Heart Rate During Resuscitation
139; 130; 161; 149; 168; 158
PRIMARY
Need for Intubation
4; 4
SECONDARY
Intraventricular Hemorrhage > Grade 2
2; 0
SECONDARY
Infants With Patent Ductus Arteriosus (PDA) Requiring Treatment
4; 1
SECONDARY
Retinopathy of Prematurity (ROP)> Stage 2
4; 1
SECONDARY
Mechanical Ventilation, Non-invasive Ventilation (NIV), and Length of Stay in Days (LOS)
14; 8.5; 15; 20.5; 52; 70.5
SECONDARY
Bronchopulmonary Dysplasia
5; 5
SECONDARY
Late Onset Sepsis
2; 0

Summary

This study hopes to determine whether nitric oxide along with oxygen during the first 20 minutes of life in infants needing help with breathing will reduce the percentage and total exposure to oxygen during that time frame. Although the use of oxygen in management of breathing is an important part of supporting baby immediately after delivery, there is more evidence that too much exposure to oxygen may lead to potential problems for your baby later. Oxygen exposure can be harmful to premature babies developing lungs.

Eligibility Criteria

Inclusion Criteria

  • Infants that are 25 0/7 - 31 6/7 weeks gestation
  • Infants who require Continuous Positive Airway Pressure (CPAP) or Positive Pressure Ventilation ( PPV) during delivery room resuscitation.

Exclusion Criteria

  • Refusal of consent
  • Known complex congenital anomalies of the heart or lungs
  • Known major genetic defects
  • Hydrops fetalis
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01220687). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search